NCT06486428Active, not recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
A Study to Evaluate a Remote, Decentralized, Direct-to-Patient Strategy for Clinical Research Engagement of Patients With Small Cell Lung Cancer (SCLC).
Source: ClinicalTrials.gov · Last updated 4 Aug 2026
Brief summary (registry, in English)
This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 22 (actual)
- First submitted
- 15 Dec 2023
- Start date
- 23 May 2025
- Primary completion date
- 15 Jul 2026
- Lead sponsor
- Addario Lung Cancer Medical Institute
- Diseases
- Lung cancer
- NCT number
- NCT06486428
What you commit to
- Study type: Observational
- Participants enrolled: 22
- From 23 May 2025 to the primary completion date, 15 Jul 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects who previously enrolled to this study
- Note: Concurrent enrollment in other clinical trials is NOT exclusionary
Other illness
- Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements
Who the study is looking for
- Men or women greater than or equal to 18 years of age at the time of consent
- Ability to read, write and communicate in English
- Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF)
- Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required
- Willing to comply with the requirements of the study
- Diagnosis of extensive stage primary SCLC or tSCLC
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Multiple Locations | United States | Unknown status |
| Vanderbilt-Ingram Cancer Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.